Quent Capital
TXG icon

Quent Capital’s 10x Genomics TXG Stock Holding History

Quent Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.03M Buy
17,402
+8,363
+93% +$489K 0.06% 153
2026
Q2 		$347K Sell
9,039
-110
-1% -$2.88K 0.02% 303
2026
Q1 		$194K Buy
9,149
+12
+0.1% +$240 0.01% 391
2025
Q4 		$149K Buy
9,137
+8,840
+2,976% +$134K 0.01% 453
2025
Q3 		$3.47K Buy
+297
New +$3.87K ﹤0.01% 1202
2025
Q2 		– Sell
-395
Closed -$3.45K – 1170
2025
Q1 		$3.45K Buy
395
+387
+4,838% +$4.88K ﹤0.01% 1072
2024
Q4 		$115 Sell
8
-8,908
-100% -$141K ﹤0.01% 1315
2024
Q3 		$201K Hold
8,916
– – 0.02% 333
2024
Q2 		$173K Buy
8,916
+4,068
+84% +$107K 0.02% 335
2024
Q1 		$182K Hold
4,848
– – 0.02% 342
2023
Q4 		$271K Hold
4,848
– – 0.04% 246
2023
Q3 		$200K Buy
4,848
+987
+26% +$51.3K 0.03% 280
2023
Q2 		$216K Hold
3,861
– – 0.03% 265
2023
Q1 		$201K Buy
3,861
+13
+0.3% +$607 0.03% 278
2022
Q4 		$140K Buy
3,848
+8
+0.2% +$262 0.03% 333
2022
Q3 		$109K Sell
3,840
-1,000
-21% -$38.1K 0.02% 359
2022
Q2 		$219K Hold
4,840
– – 0.05% 216
2022
Q1 		$368K Buy
4,840
+4,677
+2,869% +$409K 0.07% 185
2021
Q4 		$24K Buy
+163
New +$25K 0.01% 693

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Quent Capital's TXG Position: Q3 2026 in Review

Quent Capital increased its 10x Genomics (TXG) stake by 93% in Q3 2026, buying an estimated $489K and bringing the position to 17,402 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #153.

Quent Capital first reported a position in TXG in Q4 2021 and has held it in 19 quarters since. 305 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Quent Capital held 17,402 shares of 10x Genomics worth $1.03M as of Q3 2026.
  • Quent Capital bought 8,363 10x Genomics shares in Q3 2026, an estimated $489K.
  • 10x Genomics made up 0.06% of Quent Capital's portfolio in Q3 2026, its #153 holding.
  • Quent Capital first reported a position in 10x Genomics in Q4 2021 and has held it in 19 quarters since.
  • 305 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.